Claude S. Ngabonziza

Kigali, Rwanda

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study.

Spatial clustering and transmission networks of multidrug-resistant tuberculosis in Rwanda: a national retrospective genomic and spatial epidemiological study.

Journal: BMJ open

Published: August 26, 2026

Rwanda's National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response.

Rwanda's National Reference Laboratory Operational Capacity during the 2024 Marburg Virus Disease Outbreak Response.

Journal: Tropical diseases, travel medicine and vaccines

Published: February 27, 2026

Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections.

Nucleoprotein and glycoprotein based serological assays for detection of Marburg virus infections.

Journal: EBioMedicine

Published: December 05, 2025

Antimicrobial stewardship in practice: determinants of prescription behaviour and developing interventions to improve surgical prophylaxis in a Rwandan tertiary hospital-a mixed methods study using the behaviour change wheel.

Antimicrobial stewardship in practice: determinants of prescription behaviour and developing interventions to improve surgical prophylaxis in a Rwandan tertiary hospital-a mixed methods study using the behaviour change wheel.

Journal: Antimicrobial resistance and infection control

Published: November 18, 2025

Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform.

Key operational challenges at a programmatic level to achieve optimal use of the GeneXpert platform.

Journal: IJTLD open

Published: September 28, 2025

Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.

Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.

Journal: The New England journal of medicine

Published: September 10, 2025

Effectiveness of a digital clinical decision support algorithm for guiding antibiotic prescribing in pediatric outpatient care in Rwanda: A pragmatic cluster non-randomized controlled trial.

Effectiveness of a digital clinical decision support algorithm for guiding antibiotic prescribing in pediatric outpatient care in Rwanda: A pragmatic cluster non-randomized controlled trial.

Journal: PLoS medicine

Published: July 13, 2025

Implementation and evaluation of a community health workers-led digital integrated diseases screening system to provide healthcare for patients at community level in Rwanda.

Implementation and evaluation of a community health workers-led digital integrated diseases screening system to provide healthcare for patients at community level in Rwanda.

Journal: EBioMedicine

Published: July 10, 2025

Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda.

Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda.

Journal: Scientific reports

Published: April 08, 2025

Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa.

Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa.

Journal: ERJ open research

Published: March 29, 2025

Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.

Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.

Journal: Journal of clinical microbiology

Published: March 03, 2025

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

High-dose amikacin in the first week of all-oral rifampicin-resistant TB treatment is safe: a single-arm trial.

Journal: IJTLD open

Published: February 15, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026